| Q90308243 | A New Penicillin? |
| Q44399777 | A method for discrimination of subpopulations of Candida albicans biofilm cells that exhibit relative levels of phenotypic resistance to chlorhexidine |
| Q34142527 | Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm |
| Q41822185 | Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens |
| Q24550729 | Antiseptics and disinfectants: activity, action, and resistance |
| Q52677476 | Bactericidal mechanism of glutaraldehyde-didecyldimethylammonium bromide as a disinfectant against Escherichia coli. |
| Q37170954 | Chitosan sponges for local synergistic infection therapy: a pilot study |
| Q54212185 | Chlorhexidine Loaded Cyclodextrin Containing PMMA Nanogels as Antimicrobial Coating and Delivery Systems. |
| Q40696752 | Clinical and antimicrobial efficacy of a controlled-release device containing chlorhexidine in the treatment of chronic periodontitis. |
| Q24198181 | Cutaneous antisepsis for prevention of intravascular catheter-associated infection in newborn infants |
| Q38658275 | Development of antifungal therapies using nanomaterials |
| Q36367516 | Development of antimicrobial coating by later-by-layer dip coating of chlorhexidine-loaded micelles |
| Q28483654 | Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli |
| Q72459867 | Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy |
| Q33991539 | Effect of 0.2% chlorhexidine on microbial and fungal contamination of dental unit waterlines |
| Q36246092 | Efficacy of chlorhexidine for the prevention and treatment of oral mucositis in cancer patients: a systematic review with meta-analyses. |
| Q53699186 | EfrEF and the transcription regulator ChlR are required for chlorhexidine stress response in Enterococcus faecalis V583. |
| Q47657018 | Enhanced killing of Escherichia coli using a combination of polyhexamethylene biguanide hydrochloride and 1-bromo-3-chloro-5,5- dimethylimidazolidine-2,4-dione |
| Q62605414 | Evaluation of the Antimicrobial Activity and Cytotoxicity of Different Components of Natural Origin Present in Essential Oils |
| Q38550801 | Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. |
| Q43209984 | In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. |
| Q39558595 | In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea |
| Q54305940 | Intraoperative chlorhexidine irrigation to prevent infection in total hip and knee arthroplasty. |
| Q92662337 | Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens |
| Q36844668 | Minimizing human infection from Escherichia coli O157:H7 using GUMBOS. |
| Q42015036 | Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms |
| Q83865584 | Multiple exposures to chlorhexidine and xylitol: adhesion and biofilm formation by Streptococcus mutans |
| Q38798367 | Periodontal diseases as a source of halitosis: a review of the evidence and treatment approaches for dentists and dental hygienists. |
| Q43555488 | Potassium loss from chlorhexidine-treated bacterial pathogens is time- and concentration-dependent and variable between species. |
| Q35884684 | Staphylococcus aureus: an introduction |
| Q50248343 | The effects of chlorhexidine graft decontamination on tendon graft collagen and cell viability. |
| Q44224897 | The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour. |
| Q33600002 | Topical antimicrobials for burn infections - an update |
| Q34639671 | Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. |
| Q42696057 | Understanding the antimicrobial activity of selected disinfectants against methicillin-resistant Staphylococcus aureus (MRSA). |
| Q44787383 | Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity. |